|
|
|
|
Science Sparks @ ACTREC
|
 30 March 2026 |
Vol. No. 15 ; Issue No.728 |
|
|
|
|
|
|
Interesting Reads
|
|
Park W, Kasi A, Spira AI, Paz-Ares Rodríguez L, Herzberg BO, Pelster MS, Tolcher AW, Kuboki Y, Kitano S, Shoji H, Wang JS, Berlin JD, Hollebecque A, LoRusso P, Fountzilas C, Cassier PA, Nishina T, Sakai D, Inagaki C, Morgensztern D, Ueno M, Jung M, Kim SW, Jänne PA, Italiano A, You B, Macarulla T, Fujii H, Shetty A, Lu Y, Cui D, Kadam S, Gill SC, Toyoshima J, Saito T, Goldman JW(2026). Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer. New England Journal of Medicine.
|
|
|
Video of the Week
|
|
| Engineering sharper cancer immunotherapies using robotics and machine learning |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1995, Tretinoin ( Vesanoid), a drug related to vitamin A was found to cause remission in patients with acute promyelocytic leukemia (APL).
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
